Target intelligence / Profile preview

Anaerobic protozoan DNA

Molecular classification
Other (genetic material)
01

Overview

Anaerobic protozoan DNA refers to the deoxyribonucleic acid found within the nuclei of anaerobic parasitic protozoa such as *Entamoeba histolytica*, *Giardia lamblia*, and *Trichomonas vaginalis*. This DNA encodes all genetic information necessary for the survival, metabolism, and reproduction of these unicellular eukaryotes[1][2]. The structure and function of this DNA are similar to that found in other eukaryotes, being organized into chromosomes within a membrane-bound nucleus[1]. In some species, there are distinct nuclear types (e.g., micronucleus and macronucleus in ciliates), each with specialized roles[1]. While DNA itself is not a therapeutic target, it is the molecular substrate for several anti-protozoal drugs. For example, metronidazole acts by causing strand breaks or chemical modifications to the parasite's DNA under anaerobic conditions—this mechanism underlies its effectiveness against infections caused by these organisms[2]. However, "anaerobic protozoan DNA" is not a canonical drug target like an enzyme or receptor; rather, it is a general molecular component present in all living cells. There may be confusion or incorrectness in listing "anaerobic protozoan DNA" as a discrete therapeutic target. The term lacks specificity—it does not refer to a particular gene product or protein but instead denotes all nuclear genetic material from this group of organisms. Therefore, while drugs can interact with this molecule class non-selectively (e.g., via genotoxic mechanisms), it should not be considered a standard pharmacological target. In summary: > “Anaerobic protozoan DNA” describes the total genomic content within pathogenic anaerobic protists but does not represent an individual druggable entity such as an enzyme or receptor. Its inclusion as a therapeutic target is imprecise; more accurate targets would be specific enzymes involved in nucleic acid synthesis or repair unique to these pathogens[2][1]. If you need structured data on actual validated targets within these organisms—such as pyruvate:ferredoxin oxidoreductase (PFOR) or other metabolic enzymes—please specify further.

02

Mechanism of action

DNA damage and inhibition of nucleic acid synthesis by nitroimidazole drugs in anaerobic conditions

03

Biological functions

Genetic information storageRegulation of gene expression
04

Disease associations

Infection (as part of pathogenic protozoa)
05

Safety considerations

Off-target genotoxicity with some anti-protozoal agents
06

Interacting drugs

Metronidazole (targets DNA in anaerobic protozoa)

Beyond the preview

Go deeper on Anaerobic protozoan DNA.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Anaerobic protozoan DNA.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call